Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Devroey

Showing results (41-50 of 184) with videos related to

Pageof 19
Sort By:
Reproductive Biomedicine Online|February 6, 2010
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cyclesKevin Doody, Paul Devroey, Keith Gordon, et al.
Lancet (London, England)|August 17, 2010
Primary ovarian insufficiencyMichel De Vos, Paul Devroey, Bart C J M Fauser
Fertility and Sterility|January 1, 2008
First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestationEllen Anckaert, Johan Schiettecatte, Elke Sleurs, et al.
Human Reproduction Update|September 30, 2008
Infertility and the provision of infertility medical services in developing countriesWillem Ombelet, Ian Cooke, Silke Dyer, et al.
Fertility and Sterility|January 17, 2012
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transferPaul Devroey, Antonio Pellicer, Anders Nyboe Andersen, et al.
Current Pharmaceutical Biotechnology|December 8, 2010
Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort studyChristophe Blockeel, Miriam Baumgarten, Michel De Vos, et al.
Fertility and Sterility|February 9, 2011
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot studyChristophe Blockeel, Arianna Riva, Michel De Vos, et al.
Human Reproduction (Oxford, England)|February 12, 2005
Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changesEvangelos G Papanikolaou, Claire Bourgain, Efstratios Kolibianakis, et al.
Current Opinion in Obstetrics & Gynecology|May 5, 2005
Estrogen and folliculogenesis: is one necessary for the other?Efstratios M Kolibianakis, Evangelos G Papanikolaou, Human M Fatemi, et al.
Reproductive Biomedicine Online|April 12, 2005
Achievement of pregnancy three times in the same patient during luteal GnRH agonist administrationEvangelos G Papanikolaou, Peter Platteau, Carola Albano, et al.
Pageof 19

Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
Reproductive Biomedicine Online|February 6, 2010
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cyclesKevin Doody, Paul Devroey, Keith Gordon, et al.
Lancet (London, England)|August 17, 2010
Primary ovarian insufficiencyMichel De Vos, Paul Devroey, Bart C J M Fauser
Fertility and Sterility|January 1, 2008
First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestationEllen Anckaert, Johan Schiettecatte, Elke Sleurs, et al.
Human Reproduction Update|September 30, 2008
Infertility and the provision of infertility medical services in developing countriesWillem Ombelet, Ian Cooke, Silke Dyer, et al.
Fertility and Sterility|January 17, 2012
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transferPaul Devroey, Antonio Pellicer, Anders Nyboe Andersen, et al.
Current Pharmaceutical Biotechnology|December 8, 2010
Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort studyChristophe Blockeel, Miriam Baumgarten, Michel De Vos, et al.
Fertility and Sterility|February 9, 2011
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot studyChristophe Blockeel, Arianna Riva, Michel De Vos, et al.
Human Reproduction (Oxford, England)|February 12, 2005
Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changesEvangelos G Papanikolaou, Claire Bourgain, Efstratios Kolibianakis, et al.
Current Opinion in Obstetrics & Gynecology|May 5, 2005
Estrogen and folliculogenesis: is one necessary for the other?Efstratios M Kolibianakis, Evangelos G Papanikolaou, Human M Fatemi, et al.
Reproductive Biomedicine Online|April 12, 2005
Achievement of pregnancy three times in the same patient during luteal GnRH agonist administrationEvangelos G Papanikolaou, Peter Platteau, Carola Albano, et al.
Pageof 19